ARMISTICE CAPITAL, LLC - 31 Dec 2024 SCHEDULE 13G/A Report for Cyclacel Pharmaceuticals, Inc. Common Stock, par value $0.001 per share (CYCC)

Filing Manager
ARMISTICE CAPITAL, LLC
Reporting Manager
Armistice Capital, LLC
Security
Cyclacel Pharmaceuticals, Inc. Common Stock, par value $0.001 per share
Symbol
CYCC
Shares outstanding
8,425,375 shares
Disclosed Ownership
841,695 shares
Ownership
10%
Form type
SCHEDULE 13G/A
Filing time
14 Feb 2025, 17:40:40 UTC
Date of event
31 Dec 2024
Next filing
15 May 2025
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"ARMISTICE CAPITAL, LLC disclosed 10% ownership in Cyclacel Pharmaceuticals, Inc. Common Stock, par value $0.001 per share (CYCC) on 31 Dec 2024."

Quick Takeaways

  • ARMISTICE CAPITAL, LLC filed SCHEDULE 13G/A for Cyclacel Pharmaceuticals, Inc. Common Stock, par value $0.001 per share (CYCC).
  • Disclosed ownership: 10%.
  • Date of event: 31 Dec 2024.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 14 Feb 2025, 17:40.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Armistice Capital, LLC 10% 841,695 0 841,695 /s/ Steven Boyd Steven Boyd - Managing Member
Steven Boyd 10% 841,695 0 841,695 /s/ Steven Boyd Steven Boyd

Sponsored